Thirty participants will be recruited and given daily doses of a medical cannabis product.
Lifetime use of MDMA is linked to fewer suicidal thoughts, according to the US survey study.
Young cannabis consumers seem to be at a higher risk of developing long-term disabilities following a stroke, according to new research.
The study found that the cannabinoids CBDA and CBGA can bind to the spike proteins of SARS-CoV-2, making it harder for the virus to enter cells and cause infection.
The alcohol-use disorder trial, run by Awakn Life Sciences, has reported its first findings, and it seems like ketamine is a promising treatment.
Researchers from the University of Waterloo, Ontario, report that the mean price of dried flower from legal sources fell in 2019 and then again in 2020.
After commercial edibles became legally available in 2019, cannabis-related exposures were seen to be responsible for nearly 10 percent of all ED visits for poisonings in Ontario.
Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).
The company behind the trial has expanded it to include three other behavioral addictions: binge eating disorder, compulsive sexual behavior and internet gaming disorder.